SPK Acquisition Corp. SPK Acquisition Corp. (SPKAR) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on operating businesses in Asia within the telecommunications, media and technology (TMT) sectors; it offers no other products or services and has not generated revenue. Incorporated in 2020 and headquartered in Shanghai, China (specifically Room 368, 302 Buwei, 211 Fute North Road, China (Shanghai) Pilot Free Trade Zone), the company targets high-growth opportunities in the TMT industry across Asian markets. In December 2022, SPK Acquisition Corp terminated its previously announced merger agreement with Varian Biopharmaceuticals, Inc. and proceeded to redeem its public shares, liquidating its trust account as it failed to complete an initial business combination within the required timeframe; public shares were canceled effective December 29, 2022, with redemption distributions extinguishing shareholder rights.